medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2011, Number 4

<< Back Next >>

Rev Invest Clin 2011; 63 (4)

Actualidades en el tratamiento quirúrgico de las lesiones de cartílago articular

Ibarra C, Villalobos E, Izaguirre A, Velasquillo C, Masri M, Ramírez I, Ibarra LG

Language: Spanish
References: 81
Page: 423-432
PDF size: 151.43 Kb.


Text Extraction

No abstract


REFERENCES

  1. Steadman JR, Rodkey WG, Rodrigo JJ. Microfracture: surgical technique and rehabilitation to treat chondral defects. Clin Orthop Relat Res 2001; 391(Suppl.): S362-S369.

  2. Wilk KE, et al. Rehabilitation of articular lesions in the athlete’s knee. J Orthop Sports Phys Ther 2006; 36(10): 815- 27.

  3. Aigner T, et al. Independent expression of fibril-forming collagens I, II, and III in chondrocytes of human osteoarthritic cartilage. J Clin Invest 1993; 91(3): 829-37.

  4. Roughley PJ. The structure and function of cartilage proteoglycans. Eur Cell Mater 2006; 12: 92-101.

  5. Archer W, West P. The chondrocyte. Inter J Biochem Cell Biol 2003; 11: 3286-305.

  6. Mukerji, Randolph, et al. Transactions, Orthopaedic Research Society (ORS). Annual Meeting. 1997, p. 536.

  7. Poole C. Articular cartilage chondrons: form, function and failure. J Anat 1997; 191: 1-13.

  8. Mankin HJ. The reaction of articular cartilage to injury and osteoarthritis (first of two parts). N Engl J Med 1974; 291(24): 1285-92.

  9. Mankin HJ. The reaction of articular cartilage to injury and osteoarthritis (second of two parts). N Engl J Med 1974; 291(25): 1335-40.

  10. Villalobos, et al. Congreso Mundial de la International Cartilage Repair Society (ICRS), San Diego, 2006.

  11. Shapiro F, Koide S, Glimcher MJ. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg Am 1993; 75(4): 532-53.

  12. Steadman JR, et al. Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up. Arthroscopy 2003; 19(5): 477-84.

  13. Villalobos FE, et al. Reunión Anual de la American Academy of Orthopaedic Surgeons (AAOS), 2010.

  14. Knutsen G, et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am 2007; 89(10): 2105-12.

  15. Mithoefer K, et al. Return to sports participation after articular cartilage repair in the knee: scientific evidence. Am J Sports Med 2009; 37(Suppl. 1): 167S-176S.

  16. Mithoefer K, et al. Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidencebased systematic analysis. Am J Sports Med 2009; 37(10): 2053-63.

  17. Brittberg M, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994; 331(14): 889-95.

  18. O’Driscoll SW, et al. The chondrogenic potential of periosteum decreases with age. J Orthop Res 2001; 19(1): 95-103.

  19. O’Driscoll SW. Technical considerations in periosteal grafting for osteochondral injuries. Clin Sports Med 2001; 20(2): 379- 402, vii.

  20. Breinan HA, et al. Autologous chondrocyte implantation in a canine model: change in composition of reparative tissue with time. J Orthop Res 2001; 19(3): 482-92.

  21. Breinan HA, et al. Effect of cultured autologous chondrocytes on repair of chondral defects in a canine model. J Bone Joint Surg Am 1997; 79(10): 1439-51.

  22. Peterson L, et al. Autologous chondrocyte implantation: a long-term follow-up. Am J Sports Med 2010; 38(6): 1117-24.

  23. Knutsen G, et al. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am 2004; 86-A(3): 455-64.

  24. Kuettner KE, et al. Synthesis of cartilage matrix by mammalian chondrocytes in vitro. II. Maintenance of collagen and proteoglycan phenotype. J Cell Biol 1982; 93(3): 751-7.

  25. Kuettner KE, et al. Synthesis of cartilage matrix by mammalian chondrocytes in vitro. I. Isolation, culture characteristics, and morphology. J Cell Biol 1982; 93(3): 743-50.

  26. Kuriwaka M, et al. Optimum combination of monolayer and three-dimensional cultures for cartilage-like tissue engineering. Tissue Eng 2003; 9(1): 41-9.

  27. Marijnissen WJ, et al. Tissue-engineered cartilage using serially passaged articular chondrocytes. Chondrocytes in alginate, combined in vivo with a synthetic (E210) or biologic biodegradable carrier (DBM). Biomaterials 2000; 21(6): 571-80.

  28. Block JA, et al. The effects of long term monolayer culture on the proteoglycan phenotype of a clonal population of mature human malignant chondrocytes. Connect Tissue Res 1991; 26(4): 295-313.

  29. Rixen H, et al. Comparative studies on collagen expression of chondrocytes in monolayer and spheroid culture. Verh Dtsch Ges Pathol 1990; 74: 365-7.

  30. Watt FM. Effect of seeding density on stability of the differentiated phenotype of pig articular chondrocytes in culture. J Cell Sci 1988; 89 (Pt. 3): 373-8.

  31. Nixon AJ. Lust G, Vernier-Singer M. Isolation, propagation, and cryopreservation of equine articular chondrocytes. Am J Vet Res 1992; 53(12): 2364-70.

  32. Paige KT, et al. De novo cartilage generation using calcium alginate- chondrocyte constructs. Plast Reconstr Surg 1996; 97(1): 168-80.

  33. Nixon AJ, et al. Enhanced repair of extensive articular defects by insulin-like growth factor-I-laden fibrin composites. J Orthop Res 1999; 17(4): 475-87.

  34. Fortier LA, Nixon AJ, Lust G. Phenotypic expression of equine articular chondrocytes grown in three-dimensional cultures supplemented with supraphysiologic concentrations of insulinlike growth factor-1. Am J Vet Res 2002; 63(2): 301-5.

  35. Vacanti CA, et al. Joint resurfacing with cartilage grown in situ from cell-polymer structures. Am J Sports Med 1994; 22(4): 485-8.

  36. Vacanti CA, Vacanti JP. Bone and cartilage reconstruction with tissue engineering approaches. Otolaryngol Clin North Am 1994; 27(1): 263-76.

  37. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260(5110): 920-6.

  38. Vacanti CA, et al. Tissue-engineered growth of bone and cartilage. Transplant Proc 1993; 25(1, Pt. 2): 1019-21.

  39. Vacanti CA, et al. Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg 1991; 88(5): 753-9.

  40. Nehrer S, et al. Canine chondrocytes seeded in type I and type II collagen implants investigated in vitro. J Biomed Mater Res 1997; 38(2): 95-104.

  41. Nehrer S, et al. Matrix collagen type and pore size influence behavior of seeded canine chondrocytes. Biomaterials 1997; 18(11): 769-76.

  42. Nehrer S, et al. Chondrocyte-seeded collagen matrices implanted in a chondral defect in a canine model. Biomaterials 1998; 19(24): 2313-28.

  43. Marcacci M, et al. Use of autologous grafts for reconstruction of osteochondral defects of the knee. Orthopedics 1999; 22(6): 595-600.

  44. Nehrer S, Spector M, Minas T. Histologic analysis of tissue after failed cartilage repair procedures. Clin Orthop Relat Res 1999; (365): 149-62.

  45. Marcacci M, et al. New cell-based technologies in bone and cartilage tissue engineering. II. Cartilage regeneration. Chir Organi Mov 2003; 88(1): 42-7.

  46. Marcacci M, et al. New cell-based technologies in bone and cartilage tissue engineering. I. Bone reconstruction. Chir Organi Mov 2003; 88(1): 33-42.

  47. Pavesio A, et al. Hyaluronan-based scaffolds (Hyalograft C) in the treatment of knee cartilage defects: preliminary clinical findings. Novartis Found Symp 2003; 249: 203-17; 229-41.

  48. Resinger C, Vecsei V, Marlovits S. Therapeutic options in the treatment of cartilage defects. Techniques and indications. Radiologe 2004; 44(8): 756-62.

  49. Dorotka R, et al. Marrow stimulation and chondrocyte transplantation using a collagen matrix for cartilage repair. Osteoarthritis Cartilage 2005; 13(8): 655-64.

  50. Dozin B, et al. Comparative evaluation of autologous chondrocyte implantation and mosaicplasty: a multicentered randomized clinical trial. Clin J Sport Med 2005; 15(4): 220-6.

  51. Marcacci M, et al. Articular cartilage engineering with Hyalograft C: 3-year clinical results. Clin Orthop Relat Res 2005; (435): 96-105.

  52. Marlovits S, et al. Early postoperative adherence of matrix-induced autologous chondrocyte implantation for the treatment of full-thickness cartilage defects of the femoral condyle. Knee Surg Sports Traumatol Arthrosc 2005; 13(6): 451-7.

  53. Trattnig S, et al. Matrix-based autologous chondrocyte implantation for cartilage repair: noninvasive monitoring by high-resolution magnetic resonance imaging. Magn Reson Imaging 2005; 23(7): 779-87.

  54. Hollander AP, et al. Maturation of tissue engineered cartilage implanted in injured and osteoarthritic human knees. Tissue Eng 2006; 12(7): 1787-98.

  55. Marlovits S, et al. Magnetic resonance observation of cartilage repair tissue (MOCART) for the evaluation of autologous chondrocyte transplantation: determination of interobserver variability and correlation to clinical outcome after 2 years. Eur J Radiol 2006; 57(1): 16-23.

  56. Marlovits S, et al. Cartilage repair: generations of autologous chondrocyte transplantation. Eur J Radiol 2006; 57(1): 24-31.

  57. Martelli S, et al. Validation of a new protocol for computer-assisted evaluation of kinematics of double-bundle ACL reconstruction. Clin Biomech 2006; 21(3): 279-87.

  58. Nehrer S, et al. Three-year clinical outcome after chondrocyte transplantation using a hyaluronan matrix for cartilage repair. Eur J Radiol 2006; 57(1): 3-8.

  59. Trattnig S, et al. Matrix-based autologous chondrocyte implantation for cartilage repair with Hyalograft C: two-year follow-up by magnetic resonance imaging. Eur J Radiol 2006; 57(1): 9-15.

  60. Marcacci M, et al. Arthroscopic second generation autologous chondrocyte implantation. Knee Surg Sports Traumatol Arthrosc 2007 ; 15(5): 610-9.

  61. Nehrer S, et al. Results of chondrocyte implantation with a fibrin- hyaluronan matrix: a preliminary study. Clin Orthop Relat Res 2008; 466(8): 1849-55.

  62. Schlegel W, et al. Scaffold-dependent differentiation of human articular chondrocytes. Int J Mol Med 2008; 22(5): 691-9.

  63. Gobbi A, et al. Patellofemoral full-thickness chondral defects treated with second-generation autologous chondrocyte implantation: results at 5 years’ follow-up. Am J Sports Med 2009; 37(6): 1083-92.

  64. Kon E, et al. Arthroscopic second-generation autologous chondrocyte implantation compared with microfracture for chondral lesions of the knee: prospective nonrandomized study at 5 years. Am J Sports Med 2009; 37(1): 33-41.

  65. Kon E, et al. Matrix-assisted autologous chondrocyte transplantation for the repair of cartilage defects of the knee: systematic clinical data review and study quality analysis. Am J Sports Med 2009; 37(Suppl. 1): 156S-166S.

  66. Nehrer S, et al. Treatment of full-thickness chondral defects with hyalograft C in the knee: a prospective clinical case series with 2 to 7 years’ follow-up. Am J Sports Med 2009; 37(Suppl. 1): 81S-87S.

  67. Welsch GH, et al. Tibial cartilage hypertrophy due to matrixassociated autologous chondrocyte transplantation of the medial femoral condyle. A case report. J Bone Joint Surg Am 2009; 91(8): 1996-2001.

  68. Kon E, et al. Second-generation autologous chondrocyte transplantation: MRI findings and clinical correlations at a minimum 5-year follow-up. Eur J Radiol 2010.

  69. Welsch GH, et al. Evaluation of cartilage repair tissue after matrix- associated autologous chondrocyte transplantation using a hyaluronic-based or a collagen-based scaffold with morphological MOCART scoring and biochemical T2 mapping: preliminary results. Am J Sports Med 2010; 38(5): 934-42.

  70. Welsch GH, et al. T2 and T2* mapping in patients after matrixassociated autologous chondrocyte transplantation: initial results on clinical use with 3.0-Tesla MRI. Eur Radiol 2010; 20(6): 1515-23.

  71. Bekkers JE, Inklaar M, Saris DB. Treatment selection in articular cartilage lesions of the knee: a systematic review. Am J Sports Med 2009; 37(Suppl. 1): 148S-155S.

  72. De Windt TS, et al. Patient profiling in cartilage regeneration: prognostic factors determining success of treatment for cartilage defects. Am J Sports Med 2009; 37(Suppl. 1): 58S-62S.

  73. Saris DB, et al. Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture. Am J Sports Med 2009; 37(Suppl. 1): 10S-19S.

  74. Van Assche D, et al. Autologous chondrocyte implantation versus microfracture for knee cartilage injury: a prospective randomized trial, with 2-year follow-up. Knee Surg Sports Traumatol Arthrosc 2010; 18(4): 486-95.

  75. Rutgers M, et al. Evaluation of histological scoring systems for tissue-engineered, repaired and osteoarthritic cartilage. Osteoart Cartilage 2010; 18(1): 12-23.

  76. Saris DB, et al. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med 2008; 36(2): 235-46.

  77. Van den Borne MP, et al. International Cartilage Repair Society (ICRS) and Oswestry macroscopic cartilage evaluation scores validated for use in Autologous Chondrocyte Implantation (ACI) and microfracture. Osteoart Cartilage 2007; 15(12): 1397-402.

  78. Ochi M, et al. Transplantation of cartilage-like tissue made by tissue engineering in the treatment of cartilage defects of the knee. J Bone Joint Surg Br 2002; 84(4): 571-8.

  79. Erggelet C, et al. Matrix-augmented autologous chondrocyte implantation in the knee-arthroscopic technique. Oper Orthop Traumatol 2008; 20(3): 199-207.

  80. Ibarra-Ponce-de-León JC, et al. Cartilage repair: cell-based techniques. Act Ortop Mex 2009; 23(1): 38-44.

  81. Masri M, et al. Matrix-encapsulation cell-seeding technique to prevent cell detachment during arthroscopic implantation of matrix-induced autologous chondrocytes. Arthroscopy 2007; 23(8): 877-83.




2020     |     www.medigraphic.com